Income Statement Klea Holding

Stocks

ALKLH

FR0013481835

Healthcare Facilities & Services

Market Closed - Euronext Paris 11:55:00 2026-09-21 EDT			5-day change	1st Jan Change
0.1410 ^EUR	-0.70%		-11.88%	-35.62%

09-10	Klea Pharmaceuticals Receives First Order from Alphamed and Expands Distribution in the Middle East	CI
09-09	Klea Holding Launches Wellness Brand in Dubai	MT

8a18dec1b654ce1ef7edd.dGAvPfZkH1_QhkisVoDXfc27GQn-fsZvdldxiIBbaIY.HwVOapkwTwub0DjuF_W5S5uKdmW8EfIdBjEG7LMuJeBFIX1IjzVdMprLcA

Published financial data: KLEA HOLDING

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Revenues	7.17M	14.44M	13.71M	17.26M	22.17M
Other Revenues, Total	6K	-	-	-	-
Total Revenues	7.18M	14.44M	13.71M	17.26M	22.17M
Cost of Goods Sold, Total	7.79M	11.24M	7.41M	9.01M	12.38M
Gross Profit	-609K	3.2M	6.3M	8.25M	9.79M
Selling General & Admin Expenses, Total	2.98M	4.73M	4.87M	5.79M	6.32M
Depreciation & Amortization - (IS)	801K	2.6M	2M	1.63M	1.51M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses	-715K	-41K	-966K	-1.11M	-1.72M
Other Operating Expenses, Total	3.07M	7.28M	5.9M	6.31M	6.11M
Operating Income	-3.68M	-4.08M	395K	1.95M	3.68M
Interest Expense, Total	-585K	-182K	-1.2M	-758K	-849K
Interest And Investment Income	1K	4K	112K	275K	166K
Net Interest Expenses	-584K	-178K	-1.09M	-483K	-683K
Income (Loss) On Equity Invest.	-87K	136K	1K	172K	-63K
Currency Exchange Gains (Loss)	5K	-	-	-	-
Other Non Operating Income (Expenses)	3K	-	-99K	-786K	-10K
EBT, Excl. Unusual Items	-4.34M	-4.12M	-794K	850K	2.92M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-30K	-	-	-	-
Asset Writedown	-	-454K	-165K	-281K	-295K
Legal Settlements	-	-	-	-	-
Other Unusual Items	55K	-586K	1.82M	317K	249K
EBT, Incl. Unusual Items	-4.32M	-5.16M	865K	886K	2.88M
Income Tax Expense	142K	113K	-37K	-519K	595K
Earnings From Continuing Operations	-4.46M	-5.28M	902K	1.4M	2.28M
Net Income to Company	-4.46M	-5.28M	902K	1.4M	2.28M
Net Income - (IS)	-4.46M	-5.28M	902K	1.4M	2.28M
Net Income to Common Incl Extra Items	-4.46M	-5.28M	902K	1.4M	2.28M
Net Income to Common Excl. Extra Items	-4.46M	-5.28M	902K	1.4M	2.28M
Per Share Items
Net EPS - Basic	-0.07	-0.02	0	0	0.01
Basic EPS - Continuing Operations	-0.07	-0.02	0	0	0.01
Basic Weighted Average Shares Outstanding	63.14M	294M	294M	308M	308M
Net EPS - Diluted	-0.07	-0.02	0	0	0.01
Diluted EPS - Continuing Operations	-0.07	-0.02	0	0	0.01
Diluted Weighted Average Shares Outstanding	63.14M	294M	358M	370M	308M
Normalized Basic EPS	-0.04	-0.01	-0	0	0.01
Normalized Diluted EPS	-0.04	-0.01	-0	0	0.01
Supplemental Items
EBITDA	-2.88M	-1.48M	1.89M	3.57M	5.19M
EBITA	-3.67M	-3.83M	464K	2.05M	3.76M
EBIT	-3.68M	-4.08M	395K	1.95M	3.68M
EBITDAR	-2.45M	-	-	-	-
Total Revenues (As Reported)	1.65M	-	-	-	-
Effective Tax Rate - (Ratio)	-3.29	-2.19	-4.28	-58.58	20.69
Total Current Taxes	-181K	-	-10K	-393K	670K
Total Deferred Taxes	323K	113K	-27K	-126K	-75K
Normalized Net Income	-2.71M	-2.58M	-496K	531K	1.83M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Research And Development Expense From Footnotes	-	400K	-	-	-
Net Rental Expense, Total	426K	-	-	-	-
Imputed Operating Lease Interest Expense	803K	-	-	-	-
Imputed Operating Lease Depreciation	-377K	-	-	-	-
Maintenance & Repair Expenses, Total	-	-	-	-	-

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Assets
Cash And Equivalents	6.57M	2.36M	2.96M	3.3M	5.25M
Short Term Investments	-1K	-	-	-	-
Total Cash And Short Term Investments	6.56M	2.36M	2.96M	3.3M	5.25M
Accounts Receivable, Total	4.64M	1.84M	1.18M	1.66M	1.5M
Other Receivables	1.65M	2.14M	1.13M	2.15M	2.14M
Total Receivables	6.3M	3.98M	2.32M	3.81M	3.64M
Inventory	1.43M	658K	-	19K	14K
Prepaid Expenses	148K	-	-	-	-
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	1.55M	1K	-	2K	-1K
Total Current Assets	15.99M	7M	5.28M	7.14M	8.9M
Gross Property Plant And Equipment	8.53M	14.45M	7.36M	8.26M	7.45M
Accumulated Depreciation	-3.56M	-5.86M	-2.16M	-3.88M	-4.68M
Net Property Plant And Equipment	4.98M	8.59M	5.2M	4.39M	2.77M
Long-term Investments	16K	139K	-	-	-
Goodwill	21.9M	18.95M	24.6M	24.6M	24.65M
Other Intangibles, Total	89K	373K	354K	539K	281K
Deferred Charges Long-Term	0	-	-	-	-
Other Long-Term Assets, Total	1.1M	1.02M	1.17M	1.16M	685K
Total Assets	44.07M	36.08M	36.6M	37.82M	37.28M
Liabilities
Accounts Payable, Total	2.5M	2.96M	2.06M	1.65M	2.06M
Accrued Expenses, Total	1.58M	-	-	-	-
Short-term Borrowings	4.95M	5.62M	7.93M	-	-
Current Portion of Long-Term Debt	-	-	-	1.82M	5.33M
Current Income Taxes Payable	384K	1.12M	827K	1.59M	1.54M
Unearned Revenue Current, Total	2K	-	-	-	-
Deferred Tax Liability Current	17K	-	-	-	-
Other Current Liabilities	14.09M	-	-	-	-
Total Current Liabilities	23.51M	9.7M	10.81M	5.06M	8.93M
Long-Term Debt	-	-	-	4.06M	43K
Unearned Revenue Non Current	99K	-	-	-	-
Other Non Current Liabilities	6.38M	2.12M	1.04M	883K	702K
Total Liabilities	29.99M	11.81M	11.85M	10M	9.68M
Common Stock, Total	1.38M	2.94M	2.94M	3.08M	3.08M
Additional Paid In Capital	17.11M	30.14M	30.15M	36.68M	36.68M
Retained Earnings	-9.6M	-5.26M	923K	1.43M	2.3M
Treasury Stock	-	-	-	-	-295K
Comprehensive Income and Other	5.18M	-3.56M	-9.92M	-13.23M	-14.16M
Total Common Equity	14.08M	24.27M	24.1M	27.95M	27.61M
Minority Interest	-	-	647K	-128K	-
Total Equity	14.08M	24.27M	24.75M	27.82M	27.61M
Total Liabilities And Equity	44.07M	36.08M	36.6M	37.82M	37.28M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	138M	294M	294M	307M	307M
ECS Total Common Shares Outstanding	138M	294M	294M	307M	307M
Book Value / Share	0.1	0.08	0.08	0.09	0.09
Tangible Book Value	-7.92M	4.94M	-850K	2.81M	2.68M
Tangible Book Value Per Share	-0.06	0.02	-0	0.01	0.01
Total Debt	4.95M	5.62M	7.93M	5.88M	5.37M
Net Debt	-1.62M	3.26M	4.96M	2.58M	125K
Debt Equivalent Oper. Leases	3.41M	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	-	-	647K	-128K	-
Equity Method Investments, Total	3K	139K	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Work In Process, Total	100K	-	-	-	-
Inventories - Finished Goods, Total	2.56M	-	-	-	-
Inventories - Others	-	1.88M	-	-	-
Machinery, Total	6.8M	8.7M	4.86M	5.12M	4.5M
Full Time Employees	67	69	94	118	128
Accumulated Allowance for Doubtful Accounts (Supple)	164K	254K	-	-	-

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Net Income	-4.46M	-5.28M	902K	1.4M	2.28M
Depreciation & Amortization - CF	793K	2.35M	1.43M	1.52M	1.43M
Amortization of Goodwill and Intangible Assets - (CF)	8K	249K	69K	107K	83K
Depreciation & Amortization, Total	801K	2.6M	1.5M	1.63M	1.51M
(Gain) Loss From Sale Of Asset	352K	-19K	-626K	545K	-241K
Asset Writedown & Restructuring Costs	-	-	-2.37M	-	-
(Income) Loss On Equity Investments - (CF)	88K	-136K	-	-	63K
Other Operating Activities, Total	-106K	255K	1.76M	-2.01M	-135K
Change In Accounts Receivable	-	-	-	-	-
Change In Inventories	-	-	-	-	-
Change In Accounts Payable	-	-	-	-	-
Change in Other Net Operating Assets	-3.18M	838K	-54K	-638K	1.45M
Cash from Operations	-6.5M	-1.74M	1.11M	932K	4.93M
Capital Expenditure	-196K	-5.52M	-2.61M	-766K	-1.03M
Sale of Property, Plant, and Equipment	25K	53K	783K	140K	586K
Cash Acquisitions	-14.85M	-12.01M	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	-	-	266K	-	-
Cash from Investing	-15.02M	-17.47M	-1.56M	-626K	-440K
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	26M	12.17M	2.44M	1.95M	1.78M
Total Debt Issued	26M	12.17M	2.44M	1.95M	1.78M
Long-Term Debt Repaid, Total	-713K	-650K	-1.29M	-3.92M	-2.26M
Total Debt Repaid	-713K	-650K	-1.29M	-3.92M	-2.26M
Issuance of Common Stock	1.94M	3.24M	9K	1.75M	-
Repurchase of Common Stock	-	-	-	-28K	-202K
Other Financing Activities, Total	-	-	-120K	46K	-1.74M
Cash from Financing	27.23M	14.76M	1.04M	-199K	-2.42M
Foreign Exchange Rate Adjustments	62K	-	-37K	161K	-28K
Miscellaneous Cash Flow Adjustments	-	238K	1K	28K	-1K
Net Change in Cash	5.76M	-4.21M	554K	296K	2.03M
Supplemental Items
Levered Free Cash Flow	2.6M	-15.99M	-488K	442K	2.79M
Unlevered Free Cash Flow	2.96M	-15.88M	264K	916K	3.32M
Change In Net Working Capital	-4.66M	10.41M	-1.13M	1.16M	-537K
Net Debt Issued / Repaid	25.29M	11.52M	1.15M	-1.97M	-480K

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Profitability
Return on Assets	-9.2	-6.37	0.68	3.27	6.12
Return on Total Capital	-31.42	-10.43	0.79	3.67	6.89
Return On Equity %	-92.24	-27.52	3.68	5.34	8.23
Return on Common Equity	-92.24	-27.52	3.73	5.4	8.21
Margin Analysis
Gross Profit Margin %	-8.48	22.16	45.95	47.82	44.17
SG&A Margin	41.54	32.72	35.53	33.52	28.52
EBITDA Margin %	-40.06	-10.27	13.8	20.7	23.4
EBITA Margin %	-51.11	-26.54	3.39	11.9	16.97
EBIT Margin %	-51.22	-28.26	2.88	11.28	16.59
Income From Continuing Operations Margin %	-62.08	-36.53	6.58	8.14	10.29
Net Income Margin %	-62.08	-36.53	6.58	8.14	10.29
Net Avail. For Common Margin %	-62.08	-36.53	6.58	8.14	10.29
Normalized Net Income Margin	-37.78	-17.84	-3.62	3.08	8.24
Levered Free Cash Flow Margin	36.19	-110.71	-3.56	2.56	12.58
Unlevered Free Cash Flow Margin	41.29	-109.92	1.93	5.31	14.97
Asset Turnover
Asset Turnover	0.29	0.36	0.38	0.46	0.59
Fixed Assets Turnover	2.72	2.13	1.99	3.6	6.2
Receivables Turnover (Average Receivables)	2.93	4.46	9.07	12.15	14.05
Inventory Turnover (Average Inventory)	5.61	10.76	-	-	750
Short Term Liquidity
Current Ratio	0.68	0.72	0.49	1.41	1
Quick Ratio	0.55	0.65	0.49	1.41	1
Operating Cash Flow to Current Liabilities	-0.28	-0.18	0.1	0.18	0.55
Days Sales Outstanding (Average Receivables)	124.59	81.92	40.24	30.13	25.98
Days Outstanding Inventory (Average Inventory)	65.07	33.92	-	-	0.49
Average Days Payable Outstanding	178.65	353.01	-	-	54.66
Cash Conversion Cycle (Average Days)	11.01	-237.17	-	-	-28.19
Long Term Solvency
Total Debt/Equity	35.17	23.14	32.03	21.13	19.46
Total Debt / Total Capital	26.02	18.79	24.26	17.45	16.29
LT Debt/Equity	-	-	-	14.6	0.16
Long-Term Debt / Total Capital	-	-	-	12.05	0.13
Total Liabilities / Total Assets	68.06	32.74	32.37	26.44	25.95
EBIT / Interest Expense	-6.29	-22.43	0.33	2.57	4.33
EBITDA / Interest Expense	-4.92	-8.15	1.57	4.71	6.11
(EBITDA - Capex) / Interest Expense	-5.25	-38.46	-0.6	3.7	4.9
Total Debt / EBITDA	-1.72	-3.78	4.19	1.65	1.04
Net Debt / EBITDA	0.56	-2.19	2.62	0.72	0.02
Total Debt / (EBITDA - Capex)	-1.61	-0.8	-11.05	2.09	1.29
Net Debt / (EBITDA - Capex)	0.53	-0.47	-6.92	0.92	0.03
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-62.27	101.38	-5.12	25.93	28.42
Gross Profit, 1 Yr. Growth %	-83.59	-547.69	96.75	31.04	18.64
EBITDA, 1 Yr. Growth %	-53.61	-33.6	-214.53	94.5	45.17
EBITA, 1 Yr. Growth %	-43.82	26.25	-111.37	420	93.17
EBIT, 1 Yr. Growth %	-44.13	34.45	-109.68	392.91	88.91
Earnings From Cont. Operations, 1 Yr. Growth %	-13.46	18.4	-117.09	55.76	62.35
Net Income, 1 Yr. Growth %	-13.46	18.4	-117.09	55.76	62.35
Normalized Net Income, 1 Yr. Growth %	-41.1	10.59	-80.75	-207.05	54.77
Diluted EPS Before Extra, 1 Yr. Growth %	-74.48	-74.6	-116.73	58.73	84.57
Accounts Receivable, 1 Yr. Growth %	1.74K	-60.41	-35.67	40.24	-9.76
Inventory, 1 Yr. Growth %	6.47	-54.05	-	-	-26.32
Net Property, Plant and Equip., 1 Yr. Growth %	1.55K	72.71	-39.52	-15.58	-36.96
Total Assets, 1 Yr. Growth %	645.79	-18.12	1.42	3.36	-1.44
Tangible Book Value, 1 Yr. Growth %	67.32	-162.47	-117.19	-430.94	-4.8
Common Equity, 1 Yr. Growth %	-419.09	72.45	-0.7	15.97	-1.23
Cash From Operations, 1 Yr. Growth %	-40.33	-73.23	-163.81	-16.11	428.76
Capital Expenditures, 1 Yr. Growth %	-20	2.71K	-52.69	-70.64	33.94
Levered Free Cash Flow, 1 Yr. Growth %	-135.32	-533.59	-96.98	-181.42	530.62
Unlevered Free Cash Flow, 1 Yr. Growth %	-141.63	-489.7	-101.64	338.48	262.36
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-16.39	-12.86	38.23	9.31	27.17
Gross Profit, 2 Yr. CAGR %	-72.17	-7.13	196.79	60.57	24.68
EBITDA, 2 Yr. CAGR %	-62.85	-51.07	-7.99	47.07	68.04
EBITA, 2 Yr. CAGR %	-58.63	-23.39	-60.91	-29.06	208.57
EBIT, 2 Yr. CAGR %	-58.76	-21.24	-63.93	-30.94	205.15
Earnings From Cont. Operations, 2 Yr. CAGR %	-57.24	1.23	-55.01	-48.4	59.02
Net Income, 2 Yr. CAGR %	-57.24	1.23	-55.01	-48.4	59.02
Normalized Net Income, 2 Yr. CAGR %	-55.27	-25.19	-53.86	-54.6	91.84
Diluted EPS Before Extra, 2 Yr. CAGR %	-82.55	-74.54	-79.38	-52.76	66.65
Accounts Receivable, 2 Yr. CAGR %	290.25	170.14	-49.53	-5.02	12.49
Inventory, 2 Yr. CAGR %	-31.74	-30.06	-	-83.02	-
Net Property, Plant and Equip., 2 Yr. CAGR %	198.89	433.45	2.21	-28.54	-27.05
Total Assets, 2 Yr. CAGR %	72.96	147.12	-8.87	2.38	0.93
Tangible Book Value, 2 Yr. CAGR %	17.09	2.24	-67.23	-24.58	77.5
Common Equity, 2 Yr. CAGR %	66	134.58	30.86	7.31	7.02
Cash From Operations, 2 Yr. CAGR %	-46.48	-60.03	-58.67	-26.83	110.61
Capital Expenditures, 2 Yr. CAGR %	87.08	374.45	264.85	-62.73	-37.29
Levered Free Cash Flow, 2 Yr. CAGR %	-46.32	47.45	-63.63	-83.46	126.6
Unlevered Free Cash Flow, 2 Yr. CAGR %	-42.3	49.34	-74.55	-76.11	298.61
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-6.34	12.05	-10.35	34	15.34
Gross Profit, 3 Yr. CAGR %	-56.61	-25.89	19.28	126	45.16
EBITDA, 3 Yr. CAGR %	-45.22	-58.55	-32.67	16.93	46.43
EBITA, 3 Yr. CAGR %	-41.24	-43.66	-58.58	-12.21	-2.69
EBIT, 3 Yr. CAGR %	-41.32	-42.63	-60.85	-13.76	-3.41
Earnings From Cont. Operations, 3 Yr. CAGR %	-39.16	-39.95	-44.05	-31.94	-24.39
Net Income, 3 Yr. CAGR %	-39.16	-39.95	-44.05	-31.94	-24.39
Normalized Net Income, 3 Yr. CAGR %	-37.89	-42.5	-52.42	-38.91	-10.85
Diluted EPS Before Extra, 3 Yr. CAGR %	-84.47	-80.22	-77.87	-61.59	-26.91
Accounts Receivable, 3 Yr. CAGR %	68.5	82.01	67.44	-29.05	-6.63
Inventory, 3 Yr. CAGR %	-38.84	-40.17	-	-76.33	-72.3
Net Property, Plant and Equip., 3 Yr. CAGR %	67.18	148.95	158.19	-4.11	-31.47
Total Assets, 3 Yr. CAGR %	33.49	34.8	83.64	-4.97	1.09
Tangible Book Value, 3 Yr. CAGR %	23.27	-5.04	-43.57	-29.17	-18.49
Common Equity, 3 Yr. CAGR %	239.09	68.12	76.13	25.69	4.38
Cash From Operations, 3 Yr. CAGR %	-19.08	-57.52	-53.29	-47.67	41.46
Capital Expenditures, 3 Yr. CAGR %	-36.73	361.8	120.01	57.52	-42.91
Levered Free Cash Flow, 3 Yr. CAGR %	-23.36	21.05	-59.52	-50.69	-44.33
Unlevered Free Cash Flow, 3 Yr. CAGR %	-19.8	21.28	-66.66	-39.2	-40.86
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-5.44	6.66	9.42	10.94	3.1
Gross Profit, 5 Yr. CAGR %	-38.26	-11.08	-3.31	0.97	21.41
EBITDA, 5 Yr. CAGR %	-26.31	-34.87	-35.91	-29.72	-3.5
EBITA, 5 Yr. CAGR %	-23.08	-21.79	-51.93	-37.44	-10.45
EBIT, 5 Yr. CAGR %	-23.05	-20.8	-53.52	-38.21	-10.98
Earnings From Cont. Operations, 5 Yr. CAGR %	-19.78	-16.7	-46.08	-43.49	-15.03
Net Income, 5 Yr. CAGR %	-19.78	-16.7	-46.08	-43.49	-15.03
Normalized Net Income, 5 Yr. CAGR %	-20.46	-20.97	-46.5	-47.69	-16.89
Diluted EPS Before Extra, 5 Yr. CAGR %	-71.8	-77.03	-82.61	-71.99	-52.07
Accounts Receivable, 5 Yr. CAGR %	83.84	10.78	4.03	40.32	42.81
Inventory, 5 Yr. CAGR %	-13.74	-30.05	-	-63.84	-59.87
Net Property, Plant and Equip., 5 Yr. CAGR %	41.11	49.47	37.31	51.11	55.73
Total Assets, 5 Yr. CAGR %	17.82	12.38	14.59	20.76	44.54
Tangible Book Value, 5 Yr. CAGR %	24.26	-7.87	-27.44	-13.4	-10.76
Common Equity, 5 Yr. CAGR %	11.55	13.9	131.69	40.48	44.31
Cash From Operations, 5 Yr. CAGR %	-11.22	-36.17	-38.15	-47.2	-14.68
Capital Expenditures, 5 Yr. CAGR %	-26.94	52.36	27.51	68.74	33.17
Levered Free Cash Flow, 5 Yr. CAGR %	-20.34	6.42	-38.99	-45.29	-17.64
Unlevered Free Cash Flow, 5 Yr. CAGR %	-18.18	6.33	-46	-36.54	-14.16